
---
title: '非编码RNA在衰老和癌症中的新功能'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202108/24/220906oen2wz1362poha26.jpg'
author: 科学网
comments: false
date: Tue, 24 Aug 2021 21:58:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202108/24/220906oen2wz1362poha26.jpg'
---

<div>   
<p style="line-height: 2em;"><span style="font-size: 24px; font-family: 黑体, SimHei;"><span style="font-size: 24px;">非编码</span><span style="font-size: 24px; font-family: "arial black", "avant garde";">RNA</span><span style="font-size: 24px;">在衰老和癌症中的新功能</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">诸平</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202108/24/220906oen2wz1362poha26.jpg" title alt="1001.jpg" referrerpolicy="no-referrer"> </span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">据日本癌症研究基金会（</span>Japanese Foundation For Cancer Research<span style="font-size: 18px; font-family: 宋体;">简称</span>JFCR<span style="font-size: 18px; font-family: 宋体;">）</span>2021<span style="font-size: 18px; font-family: 宋体;">年</span>8<span style="font-size: 18px; font-family: 宋体;">月</span>23<span style="font-size: 18px; font-family: 宋体;">日提供的消息(<a href="https://medicalxpress.com/news/2021-08-function-noncoding-rna-senescence-cancer.html" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">A novel function of noncoding RNA in senescence and cancer</span></a>)，该基金会旗下的癌症研究所（</span>Cancer Institute at JFCR<span style="font-size: 18px; font-family: 宋体;">）的一项研究成果，于</span>8<span style="font-size: 18px; font-family: 宋体;">月</span>23<span style="font-size: 18px; font-family: 宋体;">日在领先的国际科学期刊《美国国家科学院院刊》（</span></span><a href="https://medicalxpress.com/journals/proceedings-of-the-national-academy-of-sciences/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Proceedings of the National Academy of Sciences</span></a><span style="font-family: "times new roman";"><span style="font-family: 宋体; font-size: 18px;">）网站发表——</span><span style="font-family: "times new roman"; font-size: 18px;">Kenichi Miyata, Yoshinori Imai, Satoshi Hori, Mika Nishio, Tze Mun Loo, Ryo Okada,Liying Yang, Tomoyoshi Nakadai, Reo Maruyama, Risa Fujii, Koji Ueda, Li Jiang, Hao Zheng,Shinya Toyokuni, Toyonori Sakata, Katsuhiko Shirahige, Ryosuke Kojima,Mizuho Nakayama, Masanobu Oshima, Satoshi Nagayama, Hiroyuki Seimiya,Toru Hirota, Hideyuki Saya, Eiji Hara, Akiko Takahashi. </span></span><a href="https://doi.org/10.1073/pnas.2025647118" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span><a href="https://medicalxpress.com/journals/proceedings-of-the-national-academy-of-sciences/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Proceedings of the National Academy of Sciences</span></a><span style="font-size: 18px; font-family: "times new roman";">, August 31, 2021; 118 (35): e2025647118. </span><a href="https://doi.org/10.1073/pnas.2025647118" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">https://doi.org/10.1073/pnas.2025647118</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">。此文揭示了来自于中心点周围重复序列的非编码</span>RNA<span style="font-size: 18px; font-family: 宋体;">会在衰老和癌症中引发炎症基因表达。参与此项研究的除了有来自</span>JFCR<span style="font-size: 18px; font-family: 宋体;">旗下的癌症研究所的研究人员之外，还有</span>JFCR<span style="font-size: 18px; font-family: 宋体;">旗下的癌症精准医学中心（</span>Cancer Precision Medicine Center<span style="font-size: 18px; font-family: 宋体;">）、名古屋大学医学院（</span>Nagoya University Graduate School of Medicine<span style="font-size: 18px; font-family: 宋体;">）、东京大学定量生物科学研究所（</span>Institute for Quantitative Biosciences, The University of Tokyo<span style="font-size: 18px; font-family: 宋体;">）、东京大学医学研究生院（</span>Graduate School of Medicine, The University of Tokyo<span style="font-size: 18px; font-family: 宋体;">）、日本科学技术振兴机构（</span>Japan Science and Technology Agency<span style="font-size: 18px; font-family: 宋体;">）、日本金泽大学癌症研究所（</span>Cancer Research Institute, Kanazawa University<span style="font-size: 18px; font-family: 宋体;">）、</span>JFCR’s<span style="font-size: 18px; font-family: 宋体;">癌症研究所医院（</span>Cancer Institute Hospital, Japanese Foundation for Cancer Research<span style="font-size: 18px; font-family: 宋体;">）、</span>JFCR’s<span style="font-size: 18px; font-family: 宋体;">癌症化疗中心（</span>Cancer Chemotherapy Center, Japanese Foundation for Cancer Research<span style="font-size: 18px; font-family: 宋体;">）、日本庆应大学医学院高级医学研究所（</span>Institute for Advanced Medical Research, Keio University School of Medicine<span style="font-size: 18px; font-family: 宋体;">）、大阪大学微生物疾病研究所（</span>Research Institute for Microbial Diseases, Osaka University<span style="font-size: 18px; font-family: 宋体;">）、日本医学研发机构（</span>Japan Agency for Medical Research and Development<span style="font-size: 18px; font-family: 宋体;">）的研究人员以及日本癌症研究基金会</span>NEXT-Ganken<span style="font-size: 18px; font-family: 宋体;">项目（</span>NEXT-Ganken Program, Japanese Foundation for Cancer Research<span style="font-size: 18px; font-family: 宋体;">）癌细胞交流项目（</span>Cancer Cell Communication Project<span style="font-size: 18px; font-family: 宋体;">）组成员。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">衰老是一种本质上不可逆的细胞周期阻滞状态，由多种应激源（</span>stressors<span style="font-size: 18px; font-family: 宋体;">）引起，即衰老、肥胖、放疗和化疗。衰老过程中体内积累的衰老细胞通过产生促炎蛋白（</span>proinflammatory proteins<span style="font-size: 18px; font-family: 宋体;">）与周围组织沟通，称为衰老相关分泌表型</span>(senescence associated secretory phenotype<span style="font-size: 18px; font-family: 宋体;">简称</span>SASP)<span style="font-size: 18px; font-family: 宋体;">，发挥多种生理和病理作用。在老年人中，炎性</span>SASP<span style="font-size: 18px; font-family: 宋体;">因子促进许多与年龄相关的疾病，包括癌症（</span></span><a href="https://medicalxpress.com/tags/cancer/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">cancer</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）。因此，阐明</span>SASP<span style="font-size: 18px; font-family: 宋体;">的调控机制对于开发新的年龄相关性癌症的预防和治疗策略至关重要。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">JFCR<span style="font-size: 18px; font-family: 宋体;">的一组研究人员假设，在衰老细胞中观察到的异常染色质结构（</span>aberrant chromatin architecture<span style="font-size: 18px; font-family: 宋体;">）可能与</span>SASP<span style="font-size: 18px; font-family: 宋体;">有关，并已开始使用下一代测序技术分析全基因组染色质（</span>genome-wide chromatin<span style="font-size: 18px; font-family: 宋体;">）相互作用和基因表达（</span></span><a href="https://medicalxpress.com/tags/gene+expression/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">gene expression</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）。他们发现，含有被称为人类</span>2<span style="font-size: 18px; font-family: 宋体;">号卫星</span>(human satellite II <span style="font-size: 18px; font-family: 宋体;">简称</span>hSATII)<span style="font-size: 18px; font-family: 宋体;">的中心点周围重复序列的区域，在正常细胞中是表观遗传沉默的，但在衰老细胞（</span>senescent cells<span style="font-size: 18px; font-family: 宋体;">）中显示出明显的开放状态。此外，非编码</span>RNA (noncoding RNA <span style="font-size: 18px; font-family: 宋体;">，也就是</span>hSATII RNA)<span style="font-size: 18px; font-family: 宋体;">的表达在细胞衰老过程中显著上调。进一步的分析表明，</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">通过</span>CCCTC<span style="font-size: 18px; font-family: 宋体;">结合因子</span>(CCCTC-binding factor <span style="font-size: 18px; font-family: 宋体;">简称</span>CTCF)<span style="font-size: 18px; font-family: 宋体;">的功能性损伤，干扰部分</span>SASP<span style="font-size: 18px; font-family: 宋体;">基因区域（</span>SASP gene regions<span style="font-size: 18px; font-family: 宋体;">）的染色质相互作用，从而上调</span>SASP<span style="font-size: 18px; font-family: 宋体;">样炎症基因的表达（</span>SASP-like inflammatory gene expression<span style="font-size: 18px; font-family: 宋体;">），这对维持基因组完整性至关重要。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">“肿瘤和基质细胞（</span><a href="https://medicalxpress.com/tags/stromal+cells/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">stromal cells</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）分泌的细胞外小泡</span>(extracellular vesicles<span style="font-size: 18px; font-family: 宋体;">简称</span>EVs)<span style="font-size: 18px; font-family: 宋体;">在肿瘤微环境中以非细胞自主的方式（</span>non-cell-autonomous manner<span style="font-size: 18px; font-family: 宋体;">）动态促进肿瘤的发病率和进展。有趣的是，来自衰老细胞的小</span>EVs<span style="font-size: 18px; font-family: 宋体;">中</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">的含量高于来自增殖细胞（</span>proliferating cells<span style="font-size: 18px; font-family: 宋体;">）的小</span>EVs<span style="font-size: 18px; font-family: 宋体;">中</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">的含量。因此，我们的数据提示，来自衰老基质细胞（</span>senescent stromal cells<span style="font-size: 18px; font-family: 宋体;">）的</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">通过小</span>EVs<span style="font-size: 18px; font-family: 宋体;">转移到周围细胞中，在肿瘤微环境中发挥</span>SASP<span style="font-size: 18px; font-family: 宋体;">样炎症因子（</span>SASP-like inflammatory factor<span style="font-size: 18px; font-family: 宋体;">）的作用。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">此外，研究人员发现，在原发结肠癌患者的手术标本的癌细胞中，</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">可被高度检测到。值得注意的是，在癌相关成纤维细胞（</span>cancer-associated fibroblasts<span style="font-size: 18px; font-family: 宋体;">）中，</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">阳性细胞的数量明显高于正常间质组织的成纤维细胞中的</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">阳性细胞的数量。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">“这些发现突出了</span>hSATII RNA<span style="font-size: 18px; font-family: 宋体;">的新作用，它通过分泌</span>SASP<span style="font-size: 18px; font-family: 宋体;">样炎症因子和小</span>EVs<span style="font-size: 18px; font-family: 宋体;">，支持肿瘤以非细胞自主的方式发展。了解这一分子机制有助于未来针对年龄相关疾病的新型预防和治疗策略的开发。”上述介绍，仅供参考。欲了解更多信息敬请注意浏览</span></span><a href="https://doi.org/10.1073/pnas.2025647118" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">原文</span></a><span style="font-size: 18px; font-family: "times new roman";">或者</span><a href="https://medicalxpress.com/news/2021-08-function-noncoding-rna-senescence-cancer.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">相关报道</span></a><span style="font-size: 18px; font-family: "times new roman";">。</span></p><p style="line-height: 2em;"><a href="https://medicalxpress.com/news/2021-04-mechanism-senescent-cells-genes-encoding.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">New mechanism by which senescent cells turn on genes encoding for tumor-regulating factors</span></a></p><p style="line-height: 2em;"><a href="https://www.pnas.org/content/118/35/e2025647118" style="font-size: 18px; font-family: "arial black", "avant garde"; text-decoration: underline;" target="_blank"><span style="font-family: "arial black", "avant garde";">Significance</span></a><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">During the aging process, senescent cells secrete inflammatory factors, causing various age-related pathologies. Thus, controlling the senescence-associated secretory phenotype (SASP) can tremendously benefit human health. Although SASP seems to be induced by the alteration of chromosomal organization, its underlying mechanism remains unclear. Here, it has been revealed that noncoding RNA (ncRNA) transcribed from pericentromeric repetitive elements impairs the DNA binding of CCCTC-binding factor, resulting in the alteration of chromosomal accessibility and the activation of SASP-like inflammatory genes. Notably, the ncRNA was transferred into surrounding cells via small extracellular vesicles, acting as a tumorigenic SASP factor. Our study highlights a novel mechanism regulating chromatin interaction and inflammatory gene expression in senescence and cancer.</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "arial black", "avant garde";"><strong><a href="https://www.pnas.org/content/118/35/e2025647118" target="_blank">Abstract</a></strong></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Cellular senescence causes a dramatic alteration of chromatin organization and changes the gene expression profile of proinflammatory factors, thereby contributing to various age-related pathologies through the senescence-associated secretory phenotype (SASP). Chromatin organization and global gene expression are maintained by the CCCTC-binding factor (CTCF); however, the molecular mechanism underlying CTCF regulation and its association with SASP gene expression remains unclear. We discovered that noncoding RNA (ncRNA) derived from normally silenced pericentromeric repetitive sequences directly impairs the DNA binding of CTCF. This CTCF disturbance increases the accessibility of chromatin and activates the transcription of SASP-like inflammatory genes, promoting malignant transformation. Notably, pericentromeric ncRNA was transferred into surrounding cells via small extracellular vesicles acting as a tumorigenic SASP factor. Because CTCF blocks the expression of pericentromeric ncRNA in young cells, the down-regulation of CTCF during cellular senescence triggers the up-regulation of this ncRNA and SASP-related inflammatory gene expression. In this study, we show that pericentromeric ncRNA provokes chromosomal alteration by inhibiting CTCF, leading to a SASP-like inflammatory response in a cell-autonomous and non–cell-autonomous manner and thus may contribute to the risk of tumorigenesis during aging.</span></p><p><br></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自诸平科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-212210-1301282.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-212210-1301282.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-212210-1301218.html" target="_black">患者帮助研究人员推进前列腺癌的治疗</a><br>                    <!--大赛结束-->
                                        
  
</div>
            